AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

24.43 USD
-0.58 (-2.32%)
Last: Mar 6, 2026, 12:49 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall AXR gets a fundamental rating of 7 out of 10. We evaluated AXR against 63 industry peers in the Real Estate Management & Development industry. Both the health and profitability get an excellent rating, making AXR a very profitable company, without any liquidiy or solvency issues. AXR is not valued too expensively and it also shows a decent growth rate. These ratings would make AXR suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. AXR Profitability Analysis

1.1 Basic Checks

  • AXR had positive earnings in the past year.
  • In the past year AXR had a positive cash flow from operations.
  • Each year in the past 5 years AXR has been profitable.
  • In the past 5 years AXR always reported a positive cash flow from operatings.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR has a Return On Assets of 7.49%. This is amongst the best in the industry. AXR outperforms 95.24% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.72%, AXR is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 7.10%, AXR belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AXR is above the industry average of 5.46%.
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROIC 7.1%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • AXR's Profit Margin of 22.86% is amongst the best of the industry. AXR outperforms 92.06% of its industry peers.
  • AXR's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AXR (24.45%) is better than 90.48% of its industry peers.
  • AXR's Operating Margin has declined in the last couple of years.
  • AXR's Gross Margin of 41.05% is fine compared to the rest of the industry. AXR outperforms 69.84% of its industry peers.
  • AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXR is destroying value.
  • Compared to 1 year ago, AXR has more shares outstanding
  • AXR has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AXR has been reduced compared to a year ago.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • AXR has an Altman-Z score of 21.96. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
  • AXR has a better Altman-Z score (21.96) than 96.83% of its industry peers.
  • AXR has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.01, AXR belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • AXR has a better Debt to Equity ratio (0.00) than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 21.96
ROIC/WACC0.81
WACC8.73%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • AXR has a Current Ratio of 27.73. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AXR (27.73) is better than 98.41% of its industry peers.
  • AXR has a Quick Ratio of 10.93. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR has a better Quick ratio (10.93) than 96.83% of its industry peers.
Industry RankSector Rank
Current Ratio 27.73
Quick Ratio 10.93
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • The earnings per share for AXR have decreased strongly by -15.00% in the last year.
  • Measured over the past 5 years, AXR shows a small growth in Earnings Per Share. The EPS has been growing by 2.33% on average per year.
  • Looking at the last year, AXR shows a very negative growth in Revenue. The Revenue has decreased by -27.32% in the last year.
  • Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%

3.2 Future

  • Based on estimates for the next years, AXR will show a small growth in Earnings Per Share. The EPS will grow by 2.71% on average per year.
  • The Revenue is expected to grow by 11.91% on average over the next years. This is quite good.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.46 indicates a correct valuation of AXR.
  • AXR's Price/Earnings ratio is rather cheap when compared to the industry. AXR is cheaper than 82.54% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.69. AXR is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 11.57, the valuation of AXR can be described as reasonable.
  • 93.65% of the companies in the same industry are more expensive than AXR, based on the Price/Forward Earnings ratio.
  • AXR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.79.
Industry RankSector Rank
PE 12.46
Fwd PE 11.57
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AXR is valued cheaply inside the industry as 93.65% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, AXR is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.07
EV/EBITDA 7.68
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • AXR has a very decent profitability rating, which may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • No dividends for AXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (3/6/2026, 12:49:04 PM)

24.43

-0.58 (-2.32%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-05
Earnings (Next)07-23
Inst Owners46.07%
Inst Owner Change-0.97%
Ins Owners45.02%
Ins Owner Change1.46%
Market Cap129.72M
Revenue(TTM)45.95M
Net Income(TTM)10.50M
Analysts80
Price Target23.46 (-3.97%)
Short Float %0.91%
Short Ratio4.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.09%
Min EPS beat(2)-50.49%
Max EPS beat(2)126.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)27.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 12.46
Fwd PE 11.57
P/S 2.82
P/FCF 29.07
P/OCF 25.91
P/B 0.95
P/tB 0.95
EV/EBITDA 7.68
EPS(TTM)1.96
EY8.02%
EPS(NY)2.11
Fwd EY8.64%
FCF(TTM)0.84
FCFY3.44%
OCF(TTM)0.94
OCFY3.86%
SpS8.65
BVpS25.62
TBVpS25.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.61
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROCE 8.26%
ROIC 7.1%
ROICexc 10.57%
ROICexgc 10.61%
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
FCFM 9.71%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 223.46%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 43.61%
Profit Quality 42.5%
Current Ratio 27.73
Quick Ratio 10.93
Altman-Z 21.96
F-Score5
WACC8.73%
ROIC/WACC0.81
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y-11.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y-50.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y-45.53%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 6 / 10 to AMREP CORP (AXR). This can be considered as Fairly Valued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 7 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.